Cover Image

Oxidative stress and antioxidant capacity in hereditary elliptocytosis and hereditary pyropoikilocytosis

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Supawadee Maneekesorn, Chane Choed‐Amphai, Supapitch Chanthong, Adisak Tantiworawit, Arunee Phusua, Narisara Paradee, Pimpisid Koonyosying, Somdet Srichairatanakool, Pimlak Charoenkwan
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	British Journal of Haematology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Assessment of Hepcidin‐25 and Iron Status Profiles in Pregnant Women With Thalassemia Minor
by: Thunthida Jiampochaman, et al.
Published: (2025)

Impact of HbE mutation on the clinical severity of HbH disease: A multicentre study from Thailand
by: Duantida Songdej, et al.
Published: (2024)

Cognitive impairment in hereditary spherocytosis
by: Immacolata Tartaglione, et al.
Published: (2025)

Iron overload in hereditary spherocytosis: Are genetic factors the cause?
by: Lucie Donaty, et al.
Published: (2024)

Intragenic deletions in SPTB are associated with hereditary spherocytosis: Series of 12 cases
by: Ophélie Evrard, et al.
Published: (2024)

In‐depth analysis of osmotic gradient ektacytometry parameters across different genotypes in hereditary spherocytosis
by: Jonathan R. A. de Wilde, et al.
Published: (2026)

Correction to ‘Genetic testing to identify hereditary predispositions to haematological malignancy is critical prior to allogenic haematopoietic cell transplant’
Published: (2025)

Aberrant antioxidant responses in B‐cell non‐Hodgkin lymphoma
by: Nicolas Vallet, et al.
Published: (2025)

Evaluation of some haematological variables of Acipenser persicus and Acipenser stellatus at different water temperaures
by: Pourgholam, R., et al.
Published: (2000)

Pharmacogenomic and Clinical Predictors of Deferasirox Response in Transfusion‐Dependent Thalassemia Identified Using Whole‐Genome Sequencing
by: Kittika Yampayon, et al.
Published: (2025)

Prospective implementation of the HCT frailty scale in adults with lymphoproliferative syndromes candidates for autologous haematopoietic stem cell transplantation: Results from a multicentre GETH‐TC study
by: Javier Cornago, et al.
Published: (2026)

Immune‐mediated thrombocytopenia and IL‐6‐mediated thrombocytosis observed in idiopathic multicentric Castleman disease
by: Ayelet I. Rubenstein, et al.
Published: (2024)

Indirect presentation of mismatched human leukocyte antigen ‐B associates with outcomes of cord blood transplantation
by: Takeshi Sugio, et al.
Published: (2025)

Pubertal Assessment and Growth in Patients With Hemoglobinopathies: A Longitudinal Multicenter Study on the Association With Ferritin Levels
by: J. Dülberg, et al.
Published: (2025)

Granulocyte colony‐stimulating factor may improve engraftment in adults with sickle cell disease undergoing non‐myeloablative haematopoietic stem cell transplantation
by: Shaoshi Zhu, et al.
Published: (2025)

Are there long‐term effects of combination therapy for newly diagnosed adults with ITP ?
by: Gabrielle A. Peko, et al.
Published: (2025)

Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation
by: Xiaolu Zhu, et al.
Published: (2025)

Assessment of intrathecal therapy in the treatment of familial haemophagocytic lymphohistiocytosis
by: Katarina Zivkovic, et al.
Published: (2025)

Issue Information
Published: (2024)

Efficacy of ciclosporin monotherapy in non‐severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study
by: Ken Ishiyama, et al.
Published: (2025)

Association of biomarkers of endothelial function, coagulation activation and kidney injury with persistent albuminuria in sickle cell anaemia
by: Laila Elsherif, et al.
Published: (2024)

Seeing haemoglobin SC: Challenging the misperceptions
by: Catherine Segbefia, et al.
Published: (2024)

Laboratory assessment of fetomaternal haemorrhage and Rh immune globulin management: Canadian practice and scoping review
by: Omar I. Hajjaj, et al.
Published: (2025)

Humoral and functional SARS ‐ CoV ‐2‐specific T‐cell responses elicited in chronic lymphocytic leukaemia patients with GEO ‐ CM04S1 a synthetic MVA ‐vectored COVID ‐19 vaccine
by: Sandra Ortega‐Francisco, et al.
Published: (2025)

Fetal and neonatal alloimmune thrombocytopenia ( FNAIT ): Survey of UK fetal medicine centres on antenatal management of subsequent affected pregnancies
by: Asha Aggarwal, et al.
Published: (2026)

Distinct subtypes of post‐transplant lymphoproliferative disorders: CHIP‐like mutations in early lesions and substantial mutational differences between EBV‐positive and EBV‐negative diffuse large B‐cell lymphomas
by: Vanesa‐Sindi Ivanova, et al.
Published: (2025)

Real‐World Evidence of Crizanlizumab Showing Reductions in Vaso‐Occlusive Crises and Opioid Usage in Sickle Cell Disease
by: Laurie DeBonnett, et al.
Published: (2024)

Predictors of renal response in AL amyloidosis following anti‐plasma cell therapy: The impact of baseline serum free light chain levels and light chain isotype
by: Matthew J. Rees, et al.
Published: (2026)

Is universal CAR T‐cell referral absolutely required for transplant‐ineligible patients with primary refractory or early relapsed DLBCL ?
by: Maria Dimou, et al.
Published: (2026)

Pembrolizumab and pralatrexate for relapsed or refractory peripheral T‐cell lymphomas
by: Christina Poh, et al.
Published: (2026)

Continuum of care after newborn screening for sickle cell disease: Multinational evidence from a systematic review and meta‐analysis
by: Tanveer Rehman, et al.
Published: (2026)

Low serum transferrin predicts adverse outcome in COVID ‐19 and is related to coagulation activity
by: Lukas Lanser, et al.
Published: (2026)

Correction to ‘A phase II study of ibrutinib in combination with ixazomib in patients with Waldenstrom macroglobulinaemia’
Published: (2024)

Childhood autoimmune hemolytic anemia: A scoping review
by: Caseng Zhang, et al.
Published: (2024)

Risk factors for silent cerebral infarction in immune‐mediated thrombotic thrombocytopenic survivors
by: Binish Javed, et al.
Published: (2025)

Improved Outcomes of Myeloma Cast Nephropathy in Newly Diagnosed Multiple Myeloma With Modern Anti‐Myeloma Therapies
by: Michael Sang Hughes, et al.
Published: (2025)

Clinical outcomes in patients in any phase of CML treated with ponatinib in France—Data from the TOPASE observational study
by: F. Huguet, et al.
Published: (2024)

Increased Non‐Relapse Mortality in Older People With Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine and Myeloablative Dose of Busulfan‐Based Regimen
by: Akihito Shinohara, et al.
Published: (2025)

Apoptosis and platelet biogenesis: A new piece of information on a debated topic
by: Carlo Zaninetti, et al.
Published: (2024)

Reduced‐intensity conditioning with fludarabine/busulfan versus fludarabine/low‐dose melphalan in patients with non‐Hodgkin lymphoma undergoing allogeneic haematopoietic stem cell transplantation
by: Kimimori Kamijo, et al.
Published: (2024)